LobbyingHoly Name Med CTR lobbying by quarter
Holy Name Med CTR's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $5,000. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs.
Holy Name Med CTR
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $5,000
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $20K | 1 |
| Q1 2023 | $20K | 1 |
| Q2 2023 | $25K | 1 |
| Q3 2023 | $25K | 1 |
| Q4 2023 | $25K | 1 |
| Q1 2024 | $25K | 1 |
| Q2 2024 | $25K | 1 |
| Q3 2024 | $20K | 1 |
| Q4 2024 | $15K | 1 |
| Q1 2025 | $15K | 1 |
| Q2 2025 | $10K | 1 |
| Q3 2025 | $5,000 | 1 |
| Q4 2025 | $5,000 | 1 |
| Q1 2026 | $0 | 1 |
| Q2 2026 | $0 | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$235K · 15 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Awsom Assoc | $235K | 15 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/04for Q2 | Awsom Assoc | Under $5,000 |
| 05/18for Q1 | Awsom Assoc | Under $5,000 |
| 02/05for Q4 2025 | Awsom Assoc | $5,000 |
| 25/11/06for Q3 2025 | Awsom Assoc | $5,000 |
| 25/08/14for Q2 2025 | Awsom Assoc | $10K |
| 25/05/12for Q1 2025 | Awsom Assoc | $15K |
| 25/02/04for Q4 2024 | Awsom Assoc | $15K |
| 24/11/05for Q3 2024 | Awsom Assoc | $20K |
| 24/08/14for Q2 2024 | Awsom Assoc | $25K |
| 24/05/02for Q1 2024 | Awsom Assoc | $25K |
| 24/02/05for Q4 2023 | Awsom Assoc | $25K |
| 23/11/14for Q3 2023 | Awsom Assoc | $25K |
| 23/08/07for Q2 2023 | Awsom Assoc | $25K |
| 23/05/08for Q1 2023 | Awsom Assoc | $20K |
| 23/01/24for Q4 2022 | Awsom Assoc | $20K |